Measles Group, ICMR-National Institute of Virology, Pune, Maharashtra, India.
J Med Virol. 2019 Jun;91(6):972-978. doi: 10.1002/jmv.25407. Epub 2019 Feb 5.
The Maharashtra State (MS), India, launched measles surveillance in the year 2013. From 2014 to 2017, specimens from the patients presenting with fever and skin rashes were received at the National Institute of Virology, Pune. From 36 districts of the MS, 2795 cases (1428 males and 1367 females) were referred for the laboratory diagnosis of measles and rubella using immunoglobulin M enzyme immunoassay and/or RT-PCRs. The majority of the cases (93.3%, n = 2609) were under 15 years of age. About 17.7% (494) cases had a history of measles immunization (one dose) during their childhood. Virus isolation was attempted from 107 throat swabs and 84 urine samples obtained from 191 cases using Vero hSLAM cells. The results confirmed measles in 1756 and rubella in 282 fever with rash cases by serological and molecular tools. Precisely, 170 of 382 and 35 of 149 specimens were positive for measles and rubella RT-PCRs, respectively. Sequencing of the representative PCR products showed the circulation of measles virus genotypes D4 (n = 26) and D8 (n = 107), and rubella virus genotype 2B (n = 1). Twenty-three measles viruses were isolated and genotyped, of which, 6 were D4 and 17 were D8 genotypes. Amongst the measles-immunized individuals, 51.2% (253/494) had laboratory-confirmed measles. Overall, 72.9% fever with skin rash cases (n = 2038) from the MS was laboratory confirmed for either measles or rubella. The contribution of measles was higher than rubella in the fever with rash cases. As expected, more fever with rash cases were documented in children compared with adults and highlighted the need to increase measles-rubella immunization coverage.
印度马哈拉施特拉邦(MS)于 2013 年启动了麻疹监测。从 2014 年到 2017 年,来自浦那国家病毒学研究所的患者发热和皮疹的标本。从 MS 的 36 个区,2795 例(男 1428 例,女 1367 例)因实验室诊断麻疹和风疹而转介使用免疫球蛋白 M 酶免疫测定和/或 RT-PCR。大多数病例(93.3%,n=2609)年龄在 15 岁以下。约 17.7%(494 例)的病例在儿童时期有麻疹免疫接种(一剂)史。从 191 例患者的 107 个咽喉拭子和 84 个尿液样本中尝试分离病毒,使用 Vero hSLAM 细胞。血清学和分子工具证实,1756 例发热皮疹病例为麻疹,282 例为风疹。确切地说,382 份标本中的 170 份和 149 份标本中的 35 份为麻疹和风疹 RT-PCR 阳性。代表性 PCR 产物的测序显示,麻疹病毒基因型 D4(n=26)和 D8(n=107)以及风疹病毒基因型 2B(n=1)循环。分离并基因分型了 23 株麻疹病毒,其中 6 株为 D4,17 株为 D8 基因型。在麻疹免疫个体中,51.2%(253/494)有实验室确诊的麻疹。总体而言,马哈拉施特拉邦的 72.9%(n=2038)发热皮疹病例经实验室证实为麻疹或风疹。发热皮疹病例中麻疹的比例高于风疹。不出所料,与成年人相比,儿童记录的发热皮疹病例更多,这突出表明需要增加麻疹-风疹免疫接种覆盖率。